Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Treatment Study Using Bevacizumab for Patients With Adrenocortical Carcinoma

This study has been withdrawn prior to enrollment.
(unable to enroll subjects into the study)
Sponsor:
Collaborator:
Genentech, Inc.
Information provided by:
Dartmouth-Hitchcock Medical Center
ClinicalTrials.gov Identifier:
NCT00469469
First received: May 2, 2007
Last updated: April 21, 2015
Last verified: May 2008
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: September 2009
  Estimated Primary Completion Date: No date given